Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,830
Closed -$226K 87
2019
Q2
$226K Hold
2,830
0.02% 89
2019
Q1
$225K Hold
2,830
0.02% 106
2018
Q4
$206K Buy
+2,830
New +$200K 0.02% 90
2016
Q4
Sell
-9,353
Closed -$557K 112
2016
Q3
$557K Hold
9,353
0.09% 105
2016
Q2
$514K Hold
9,353
0.09% 105
2016
Q1
$472K Buy
+9,353
New +$458K 0.09% 105
2015
Q4
Sell
-6,760
Closed -$319K 115
2015
Q3
$319K Sell
6,760
-2,730
-29% -$145K 0.06% 102
2015
Q2
$516K Buy
+9,490
New +$532K 0.08% 90

Other funds holding MRK

NS Partners's MRK Position: Q3 2019 in Review

NS Partners sold out of Merck (MRK) in Q3 2019, closing a stake of 2,830 shares — an estimated $226K sold.

NS Partners first reported a position in MRK in Q2 2015 and held it in 8 quarters. The position peaked at $557K in Q3 2016. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • NS Partners reported no remaining Merck position as of Q3 2019 after selling out during the quarter.
  • NS Partners sold 2,830 Merck shares in Q3 2019, an estimated $226K.
  • NS Partners first reported a position in Merck in Q2 2015 and held it in 8 quarters.
  • NS Partners's Merck position peaked at $557K in Q3 2016.
  • 2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on NS Partners's 13F filing for Q3 2019, filed 13 Nov 2019.